Business Description
HilleVax Inc
NAICS : 541714
SIC : 2834
ISIN : US43157M1027
Description
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.8 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | -0.34 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -184.7 | |||||
3-Year EPS without NRI Growth Rate | -186.7 | |||||
3-Year FCF Growth Rate | -213.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 24.87 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.94 | |||||
9-Day RSI | 43.85 | |||||
14-Day RSI | 30.65 | |||||
6-1 Month Momentum % | -87.74 | |||||
12-1 Month Momentum % | -85.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.14 | |||||
Quick Ratio | 5.14 | |||||
Cash Ratio | 4.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -43 | |||||
Shareholder Yield % | -144.99 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -63.69 | |||||
ROA % | -49.17 | |||||
ROIC % | -363.27 | |||||
ROC (Joel Greenblatt) % | -510.45 | |||||
ROCE % | -52.97 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.46 | |||||
Price-to-Tangible-Book | 0.47 | |||||
EV-to-EBIT | 0.64 | |||||
EV-to-EBITDA | 0.66 | |||||
EV-to-FCF | 0.77 | |||||
Price-to-Net-Current-Asset-Value | 0.53 | |||||
Price-to-Net-Cash | 0.55 | |||||
Earnings Yield (Greenblatt) % | 156.25 | |||||
FCF Yield % | -134.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HLVX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HilleVax Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -3.39 | ||
Beta | 0 | ||
Volatility % | 106.36 | ||
14-Day RSI | 30.65 | ||
14-Day ATR ($) | 0.267705 | ||
20-Day SMA ($) | 1.75955 | ||
12-1 Month Momentum % | -85.13 | ||
52-Week Range ($) | 1.55 - 20.22 | ||
Shares Outstanding (Mil) | 49.78 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HilleVax Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HilleVax Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
HilleVax Inc Frequently Asked Questions
What is HilleVax Inc(HLVX)'s stock price today?
The current price of HLVX is $1.94. The 52 week high of HLVX is $20.22 and 52 week low is $1.55.
When is next earnings date of HilleVax Inc(HLVX)?
The next earnings date of HilleVax Inc(HLVX) is 2024-11-08 Est..
Does HilleVax Inc(HLVX) pay dividends? If so, how much?
HilleVax Inc(HLVX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |